Gut microbiota profoundly shapes immunity in humans. Dysbiosis, a disturbance in the quantity and composition of gut microbiota, leads to aberrant immune development and functioning and increases the risk of various diseases, including cancer. The effects of dysbiosis on non-gastrointestinal (non-GI) cancers are largely unknown. Moreover, the mechanistic effects of dysbiosis on endothelial-mediated immune surveillance in non-GI primary tumor microenvironment (TME) are unexplored. The goal of this proposal is to unravel the mechanisms by which dysbiosis impairs immune surveillance (via leukocyte extravasation and subsequent activation), specifically focusing on endothelial cell/stroma modulation. Our objective is to delineate the systemic influence of dysbiosis-generated cytokine profiles on endothelial-associated immune surveillance in non-GI TME. Based on our preliminary studies, our central hypothesis is that changes in cytokine expression during dysbiosis downregulate endothelial adhesion molecules (EAMs) such as ICAM-1, VCAM, and E- selectin. These EAMs are crucial for leukocytes to bind and adhere to tumor endothelial cells and transmigrate into the tumor, while therapeutics that upregulate EAMs improve extravasation. In particular, we will investigate the dysbiosis-induced modulation of EAMs in two primary non-GI tumors?melanoma and ovarian cancer?and the leukocyte extravasation enhancement effects by compounds that modulate EAMs. In the following Specific Aims we will test our hypothesis by measuring and analyzing: the induction of dysbiosis, changes in microbiota, non?tumor-EAMs and tumor-EAMs, tumor growth curves, serum cytokine levels, and leukocyte extravasation in nontumor tissues and in tumors by using our established methods (e.g., 16S rRNA sequencing, real-time imaging and in vivo flow cytometry, immunofluorescence). We will associate changes in microbiota (abundance, diversity, and composition) with the downstream effects on EAMs and leukocyte extravasation in tumor-bearing and non?tumor-bearing mice with and without cancer therapeutics.
Specific Aim 1. Characterize the effects of dysbiosis on EAM expression and leukocyte-endothelial interactions in non?tumor-bearing mice.
Specific Aim 2. Characterize the effects of dysbiosis on endothelial-based immune surveillance in tumors.
Specific Aim 3. Enhance tumoral leukocyte extravasation by modulating EAM expression during dysbiosis. This research is significant because determining if dysbiosis contributes to tumor progression by modulating the TME will improve our understanding of microbiota and cancer crosstalk in melanoma and ovarian tumors, which could lead to novel cancer therapeutics and increase the efficacy of existing ones.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
2P20GM103625-06
Application #
9150923
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
6
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Type
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Kennedy, J L; Denson, J L; Schwalm, K S et al. (2017) Complete Genome Sequence of a Novel WU Polyomavirus Isolate from Arkansas, USA, Associated with Acute Respiratory Infection. Genome Announc 5:
Lei, Mei G; Gupta, Ravi Kr; Lee, Chia Y (2017) Proteomics of Staphylococcus aureus biofilm matrix in a rat model of orthopedic implant-associated infection. PLoS One 12:e0187981
Koonce, Nathan A; Griffin, Robert J; Dings, Ruud P M (2017) Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models. Int J Mol Sci 18:
Kieber-Emmons, Thomas; Monzavi-Karbassi, Behjatolah; Hutchins, Laura F et al. (2017) Harnessing benefit from targeting tumor associated carbohydrate antigens. Hum Vaccin Immunother 13:323-331
Kaldhone, Pravin R; Khajanchi, Bijay K; Han, Jing et al. (2017) Draft Genome Sequences of Salmonella enterica Isolates Containing Incompatibility Group I1 Plasmids from Swine, Poultry, and Human Sources. Genome Announc 5:
Hartman, Jessica H; Miller, Grover P; Caro, Andres A et al. (2017) 1,3-Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice. Toxicology 378:114-124
Khajanchi, Bijay K; Hasan, Nur A; Choi, Seon Young et al. (2017) Comparative genomic analysis and characterization of incompatibility group FIB plasmid encoded virulence factors of Salmonella enterica isolated from food sources. BMC Genomics 18:570
Simon, Emily J; Howells, Morgan A; Stuart, Johnasha D et al. (2017) Serotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus. Viruses 9:
Holthoff, Emily R; Byrum, Stephanie D; Mackintosh, Samuel G et al. (2017) Vulvar squamous cell carcinoma aggressiveness is associated with differential expression of collagen and STAT1. Clin Proteomics 14:40
Nounamo, Bernice; Li, Yibo; O'Byrne, Peter et al. (2017) An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function. Virology 503:94-102

Showing the most recent 10 out of 95 publications